Guangzhou Baiyunshan Pharmaceutical Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SZSC:874 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 Nov 24	SellHK$6,282,270	Norges Bank Investment Management	Company	348,000	HK$18.05
20 Nov 24	SellHK$5,295,391	Norges Bank Investment Management	Company	292,000	HK$18.13
14 Nov 24	SellHK$12,159,166	Norges Bank Investment Management	Company	664,000	HK$18.31
08 Nov 24	SellHK$10,322,695	Norges Bank Investment Management	Company	540,000	HK$19.12
01 Nov 24	SellHK$14,836,095	Norges Bank Investment Management	Company	808,000	HK$18.36
29 Oct 24	SellHK$7,582,070	Norges Bank Investment Management	Company	404,000	HK$18.77
23 Oct 24	SellHK$15,310,540	Norges Bank Investment Management	Company	794,000	HK$19.28
17 Oct 24	SellHK$11,659,005	Norges Bank Investment Management	Company	618,000	HK$18.87
14 Oct 24	SellHK$12,960,174	Norges Bank Investment Management	Company	662,000	HK$19.58
09 Oct 24	SellHK$36,989,058	Norges Bank Investment Management	Company	1,680,000	HK$22.02
04 Oct 24	SellHK$10,693,500	Norges Bank Investment Management	Company	506,000	HK$21.13
30 Sep 24	SellHK$3,836,009	Norges Bank Investment Management	Company	186,000	HK$20.62

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 874?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	2,300	0.000141%
Institutions	311,504,253	19.2%
General Public	564,711,341	34.7%
Private Companies	749,573,055	46.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 63.79% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
45%	Guangzhou Pharmaceutical Holdings Limited	732,305,103	HK$21.4b	0%	no data
4.16%	Guangzhou China Life Insurance Urban Development Industry Investment Enterprises (LP)	67,576,183	HK$2.0b	0%	87.43%
2.91%	China Securities Finance Corp, Asset Management Arm	47,277,962	HK$1.4b	0%	0.22%
2.09%	Norges Bank Investment Management	33,955,879	HK$991.5m	-41.7%	0.01%
1.22%	E Fund Management Co., Ltd.	19,853,370	HK$579.7m	95.7%	0.09%
1.06%	Guangzhou Industrial Investment and Capital Operation Holding Group Ltd.	17,267,952	HK$504.2m	0%	no data
0.81%	LSV Asset Management	13,186,111	HK$385.0m	0%	0.06%
0.81%	Huatai-PineBridge Fund Management Co., Ltd.	13,118,792	HK$383.1m	457%	0.12%
0.77%	The Vanguard Group, Inc.	12,577,308	HK$367.2m	0.27%	no data
0.54%	China Asset Management Co. Ltd.	8,795,136	HK$256.8m	0%	0.04%
0.53%	Zhong Ou Fund Management Co., Ltd	8,680,636	HK$253.5m	0%	0.13%
0.53%	Bosera Asset Management Co., Ltd.	8,662,836	HK$252.9m	0%	0.15%
0.53%	Dacheng Fund Management Co., Ltd.	8,657,836	HK$252.8m	0%	0.21%
0.38%	Harvest Fund Management Co. Ltd.	6,245,852	HK$182.4m	0%	0.05%
0.32%	China Universal Asset Management Company Ltd.	5,247,676	HK$153.2m	0%	0.07%
0.3%	Dimensional Fund Advisors LP	4,806,604	HK$140.3m	0.5%	no data
0.28%	First Seafront Fund Management Co., Ltd	4,613,600	HK$134.7m	0%	0.22%
0.28%	BlackRock, Inc.	4,509,887	HK$131.7m	-15.8%	no data
0.23%	China Merchants Fund Management Company Ltd.	3,718,630	HK$108.6m	0%	0.05%
0.21%	Zhongrong Fund Management Co., Ltd.	3,399,300	HK$99.3m	0%	1.1%
0.2%	Hongde Fund Management Co., Ltd.	3,332,152	HK$97.3m	0%	0.3%
0.2%	Fullgoal Fund Management Co. Ltd.	3,222,303	HK$94.1m	0%	0.03%
0.16%	GF Fund Management Co., Ltd.	2,673,013	HK$78.0m	0%	0.02%
0.12%	Tianhong Asset Management Co., Ltd.	1,923,907	HK$56.2m	0%	0.04%
0.09%	Penghua Fund Management Co., Ltd.	1,461,029	HK$42.7m	-6.46%	0.03%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 12:41
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is covered by 29 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Zhi Xue Diao	Avic Securities Co., Ltd
null null	BOCI Research Ltd.
Feng Qiang Sun	BOCOM International Securities Limited